MPMathias Paul

Mathias Paul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mathias Paul has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bias Enhanced Electro-Photocatalysis on TiO2 Nanoporous Materials for Decomposition of Forever Chemicals in Saltwater

    by Sapanbir Thind, Bobby Ryane, John Hayden, Ian Chagunda, Mathias Paul, Jackie Hayden, Scott McIndoe

    In this study, a TiO2-based bias-enhanced photocatalytic system was prepared with the aim of achieving high photocatalytic activity in deionized as well as in saltwater systems. Highly ordered TiO2 nanoporous materials were fabricated via a double-anodization method. A small potential bias was applied that suppresses electron-hole recombination and deters interference from the ions present in the solution while minimizing electrochemical reactions. Photodegradation reactions involving Rhodamine B (RhB) were conducted to evaluate the efficacy of the nanomaterials with and without the applied bias. Our experimental results revealed that the synthesized TiO2 nanomaterials possessed high photochemical activity under UVA light, substantially enhanced with the applied bias. A very significant enhancement was observed when the Bias Enhanced Electrolytic Photocatalysis (BEEP) system was used in saline solutions. Higher photocatalytic efficiency was achieved with the increase in the salinity level in the reaction mixture. These bias-enhanced nanomaterials were successfully tested for the degradation of per- and polyfluorinated substances (PFAS), recognized as a significant threat to the environment and human health. The results indicated that the presented technology could eliminate a wide range of fluorinated molecules. The simplicity, efficacy and scalability of the new BEEP approach described in this study make the use of TiO2-based advanced oxidation process (AOP) possible in designing high-performance water purification technologies applicable to fresh and salt water.

  • Open Access

    Metabolite Identification Using Infrared Ion Spectroscopy─Novel Biomarkers for Pyridoxine-Dependent Epilepsy

    by Rianne E. van Outersterp, Udo F.H. Engelke, Jona Merx, Giel Berden, Mathias Paul, Thomas Thomulka, Albrecht Berkessel, Marleen C.D.G. Huigen, Leo A.J. Kluijtmans, Jasmin Mecinović, et al.


  • Open Access

    Metabolite Identification Using Infrared Ion Spectroscopy – Novel Biomarkers for Pyridoxine-Dependent Epilepsy

    by Rianne E. van Outersterp, Udo F. H. Engelke, Jona Merx, Giel Berden, Mathias Paul, Thomas Thomulka, Albrecht Berkessel, Marleen C. D. G. Huigen, Leo A. J. Kluijtmans, Jasmin Mecinović, et al.

    Untargeted LC-MS based metabolomics strategies are being increasingly applied in metabolite screening for a wide variety of medical conditions. The long-standing “grand challenge” in the utilization of this approach is metabolite identification – confidently determining the chemical structures of m/z-detected unknowns. Here, we use a novel workflow based on the detection of molecular features of interest by high-throughput untargeted LC-MS analysis of patient body fluids combined with targeted molecular identification of those features using infrared ion spectroscopy (IRIS), effectively providing diagnostic IR fingerprints for mass-isolated targets. A significant advantage of this approach is that in silico predicted IR spectra of candidate chemical structures can be used to suggest the molecular structure of unknown features, thus mitigating the need for the synthesis of a broad range of physical reference standards. Pyridoxine dependent epilepsy (PDE-ALDH7A1) is an inborn error of lysine metabolism, resulting from a mutation in the ALDH7A1 gene that leads to an accumulation of toxic levels of α-aminoadipic semialdehyde (α-AASA), piperideine-6-carboxylate (P6C), and pipecolic acid in body fluids. While α-AASA and P6C are known biomarkers for PDE in urine, their instability makes them poor candidates for diagnostic analysis from blood, which would be required for application in newborn screening protocols. Here, we use combined untargeted metabolomics-IRIS to identify several new biomarkers for PDE-ALDH7A1 that can be used for diagnostic analysis in urine, plasma, and cerebrospinal fluids, and are compatible with analysis in dried blood spots for newborn screening. The identification of these novel metabolites has directly rendered novel insights in the pathophysiology of PDE-ALDH7A1.


  • Open Access

    Cover Feature: Breslow Intermediates (Amino Enols) and Their Keto Tautomers: First Gas‐Phase Characterization by IR Ion Spectroscopy (Chem. Eur. J. 8/2021)

    by Mathias Paul, Katrin Peckelsen, Thomas Thomulka, Jonathan Martens, Giel Berden, Jos Oomens, Jörg‐M. Neudörfl, Martin Breugst, Anthony J. H. M. Meijer, Mathias Schäfer, et al.

  • Open Access

    Breslow Intermediates (Amino Enols) and Their Keto Tautomers: First Gas‐Phase Characterization by IR Ion Spectroscopy

    by Mathias Paul, Katrin Peckelsen, Thomas Thomulka, Jonathan Martens, Giel Berden, Jos Oomens, Jörg‐M. Neudörfl, Martin Breugst, Anthony J. H. M. Meijer, Mathias Schäfer, et al.

    Breslow intermediates (BIs) are the crucial nucleophilic amino enol intermediates formed from electrophilic aldehydes in the course of N‐heterocyclic carbene (NHC)‐catalyzed umpolung reactions. Both in organocatalytic and enzymatic umpolung, the question whether the Breslow intermediate exists as the nucleophilic enol or in the form of its electrophilic keto tautomer is of utmost importance for its reactivity and function. Herein, the preparation of charge‐tagged Breslow intermediates/keto tautomers derived from three different types of NHCs (imidazolidin‐2‐ylidenes, 1,2,4‐triazolin‐5‐ylidenes, thiazolin‐2‐ylidenes) and aldehydes is reported. An ammonium charge tag is introduced through the aldehyde unit or the NHC. ESI‐MS IR ion spectroscopy allowed the unambiguous conclusion that in the gas phase, the imidazolidin‐2‐ylidene‐derived BI indeed exists as a diamino enol, while both 1,2,4‐triazolin‐5‐ylidenes and thiazolin‐2‐ylidenes give the keto tautomer. This result coincides with the tautomeric states observed for the BIs in solution (NMR) and in the crystalline state (XRD), and is in line with our earlier calculations on the energetics of BI keto–enol equilibria.


  • Hydrogen tunneling avoided: enol-formation from a charge-tagged phenyl pyruvic acid derivative evidenced by tandem-MS, IR ion spectroscopy and theory

    by Mathias Paul, Katrin Peckelsen, Thomas Thomulka, Jörg Neudörfl, Jonathan Martens, Giel Berden, Jos Oomens, Albrecht Berkessel, Anthony J. H. M. Meijer, Mathias Schäfer

    A charge-tagged phenyl pyruvic acid derivative was investigated by tandem-MS, infrared (IR) ion spectroscopy and theory. The tailor-made precursor ions efficiently lose CO2 in collision induced dissociation (CID) experiments, offering access to study the secondary decay reactions of the product ions. IR ion spectroscopy provides evidence for the formation of an enol acid precursor ion structure in the gas phase and indicates the presence of enol products formed after CO2 loss. Extensive DFT computations however, suggest intermediate generation of hydroxycarbene products, which in turn rearrange in a secondary process to the enol ions detected by IR ion spectroscopy. Quantum mechanical tunneling of the hydroxycarbene can be excluded since no evidence for aldehyde product ion formation could be found. This finding is in contrast to the behavior of methylhydroxycarbene, which cleanly penetrates the energy barrier to form exclusively acetaldehyde at cryogenic temperatures in an argon matrix via quantum mechanical hydrogen tunneling. The results presented here are attributed to the highly excited energy levels of the product ions formed by CID in combination with different barrier heights of the competing reaction channels, which allow exclusive access over one energy barrier leading to the formation of the enol tautomer ions observed.


  • Breslow Intermediates from a Thiazolin‐2‐ylidene and Fluorinated Aldehydes: XRD and Solution‐Phase NMR Spectroscopic Characterization

    by Mathias Paul, Jörg‐M. Neudörfl, Albrecht Berkessel

    The first generation and X‐ray diffraction (XRD) analysis of a crystalline Breslow intermediate (BI) derived from a thiazolin‐2‐ylidene, that is, the aromatic heterocycle present in vitamin B1, is reported. Key to success was the combined use of pentafluorobenzaldehyde and a thiazolin‐2‐ylidene carrying an enol‐stabilizing dispersion energy donor as N‐substituent. A so‐called primary intermediate (PI) could be isolated in protonated form (pPI) as well and analyzed by XRD. Furthermore, the first stable BI derived from an aromatic thiazolin‐2‐ylidene and an aliphatic aldehyde (trifluoroacetaldehyde) was prepared and characterized by NMR spectroscopy in solution. When switching to a saturated thiazolidin‐2‐ylidene, reaction with pentafluorobenzaldehyde afforded a new BI in solution (NMR spectroscopy). Attempts to crystallize the latter BI resulted in the isolation of a novel thiazolidin‐2‐ylidene dimer that had undergone rearrangement to a hexahydro[1,4]‐thiazino[3,2‐b]‐1,4‐thiazine.


  • Breslow Intermediates from a Thiazolin‐2‐ylidene and Fluorinated Aldehydes: XRD and Solution‐Phase NMR Spectroscopic Characterization

    by Mathias Paul, Jörg‐M. Neudörfl, Albrecht Berkessel

    The first generation and X‐ray diffraction (XRD) analysis of a crystalline Breslow intermediate (BI) derived from a thiazolin‐2‐ylidene, that is, the aromatic heterocycle present in vitamin B1, is reported. Key to success was the combined use of pentafluorobenzaldehyde and a thiazolin‐2‐ylidene carrying an enol‐stabilizing dispersion energy donor as N‐substituent. A so‐called primary intermediate (PI) could be isolated in protonated form (pPI) as well and analyzed by XRD. Furthermore, the first stable BI derived from an aromatic thiazolin‐2‐ylidene and an aliphatic aldehyde (trifluoroacetaldehyde) was prepared and characterized by NMR spectroscopy in solution. When switching to a saturated thiazolidin‐2‐ylidene, reaction with pentafluorobenzaldehyde afforded a new BI in solution (NMR spectroscopy). Attempts to crystallize the latter BI resulted in the isolation of a novel thiazolidin‐2‐ylidene dimer that had undergone rearrangement to a hexahydro[1,4]‐thiazino[3,2‐b]‐1,4‐thiazine.


  • Intermediates of N‐Heterocyclic Carbene (NHC) Dimerization Probed in the Gas Phase by Ion Mobility Mass Spectrometry: C−H⋅⋅⋅:C Hydrogen Bonding Versus Covalent Dimer Formation

    by Mathias Paul, Eric Detmar, Maria Schlangen, Martin Breugst, Jörg‐Martin Neudörfl, Helmut Schwarz, Albrecht Berkessel, Mathias Schäfer

    N‐Heterocyclic carbenes (NHCs, :C) can interact with azolium salts (C−H+) by either forming a hydrogen‐bonded aggregate (CHC+) or a covalent C−C bond (CCH+). In this study, the intramolecular NHC–azolium salt interactions of aromatic imidazolin‐2‐ylidenes and saturated imidazolidin‐2‐ylidenes have been investigated in the gas phase by traveling wave ion mobility mass spectrometry (TW IMS) and DFT calculations. The TW IMS experiments provided evidence for the formation of these important intermediates in the gas phase, and they identified the predominant aggregation mode (hydrogen bond vs. covalent C−C) as a function of the nature of the interacting carbene–azolium pairs.